Published in PLoS Pathog on February 13, 2014
Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog (2015) 1.11
Mechanisms of neutralization of a human anti-α-toxin antibody. J Biol Chem (2014) 0.98
Synergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal Sepsis. Cell Host Microbe (2015) 0.87
Divergent Isoprenoid Biosynthesis Pathways in Staphylococcus Species Constitute a Drug Target for Treating Infections in Companion Animals. mSphere (2016) 0.86
Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy. Toxins (Basel) (2016) 0.81
Interfering with Bacterial Quorum Sensing. Perspect Medicin Chem (2016) 0.81
Whole-Genome Sequence of Multidrug-Resistant Staphylococcus caprae Strain 9557, Isolated from Cerebrospinal Fluid. Genome Announc (2015) 0.81
DNA microarray analysis of Staphylococcus aureus causing bloodstream infection: bacterial genes associated with mortality? Eur J Clin Microbiol Infect Dis (2016) 0.81
Genome Analysis of Staphylococcus agnetis, an Agent of Lameness in Broiler Chickens. PLoS One (2015) 0.80
Structure of the 70S ribosome from human pathogen Staphylococcus aureus. Nucleic Acids Res (2016) 0.78
Enhancement of the pathogenicity of Staphylococcus aureus strain Newman by a small noncoding RNA SprX1. Med Microbiol Immunol (2016) 0.77
Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease. MBio (2016) 0.77
Bacterial iron-sulfur cluster sensors in mammalian pathogens. Metallomics (2015) 0.77
High Frequency and Diversity of Antimicrobial Activities Produced by Nasal Staphylococcus Strains against Bacterial Competitors. PLoS Pathog (2016) 0.76
Staphylococcus aureus Regulatory RNAs as Potential Biomarkers for Bloodstream Infections. Emerg Infect Dis (2016) 0.76
Staphylococcus aureus Tissue Infection During Sepsis Is Supported by Differential Use of Bacterial or Host-Derived Lipoic Acid. PLoS Pathog (2016) 0.75
Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us. PLoS Pathog (2016) 0.75
Complete genome of Staphylococcus aureus Tager 104 provides evidence of its relation to modern systemic hospital-acquired strains. BMC Genomics (2016) 0.75
Humanized Mouse Models of Staphylococcus aureus Infection. Front Immunol (2017) 0.75
Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies. Pediatr Crit Care Med (2017) 0.75
Multi-mechanistic monoclonal antibodies targeting S. aureus α-toxin and clumping factor A: Activity and efficacy comparisons of a mAb combination and an engineered bispecific antibody approach. Antimicrob Agents Chemother (2017) 0.75
Strain Level Streptococcus Colonization Patterns during the First Year of Life. Front Microbiol (2017) 0.75
The identification of Staphylococcus aureus factors required for pathogenicity and growth in human blood. Infect Immun (2017) 0.75
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Staphylococcus aureus infections. N Engl J Med (1998) 36.39
Management of sepsis. N Engl J Med (2006) 9.01
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med (2007) 7.75
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2009) 3.89
Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol (2012) 2.98
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med (2004) 2.96
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol (2005) 2.82
Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J (2009) 2.82
Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol (2007) 2.46
Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol (2006) 2.40
The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci U S A (1995) 2.36
Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol (2007) 2.19
The GENESIS project (GENeralized Early Sepsis Intervention Strategies): a multicenter quality improvement collaborative. J Intensive Care Med (2012) 2.05
Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel) (2013) 1.99
Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host Microbe (2013) 1.99
Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc Natl Acad Sci U S A (2006) 1.91
Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets. J Exp Med (1988) 1.79
Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med (2010) 1.77
Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera. J Immunol Methods (1983) 1.75
Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol (2010) 1.71
Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A (2011) 1.70
Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock (2012) 1.69
Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol (2011) 1.64
Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death. Microb Pathog (2002) 1.61
Confinement-induced quorum sensing of individual Staphylococcus aureus bacteria. Nat Chem Biol (2009) 1.61
Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J Immunol (2004) 1.59
Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog (2011) 1.57
ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin. J Infect Dis (2012) 1.56
Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol (2013) 1.46
Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell Microbiol (2006) 1.38
Staphylococcus aureus leukotoxin GH promotes inflammation. J Infect Dis (2012) 1.30
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front Cell Infect Microbiol (2012) 1.29
Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. Proc Natl Acad Sci U S A (2004) 1.25
Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog (2010) 1.24
The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase. FEMS Microbiol Lett (2004) 1.22
Superantigens are critical for Staphylococcus aureus Infective endocarditis, sepsis, and acute kidney injury. MBio (2013) 1.19
The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinct. PLoS One (2011) 1.16
Breaking the wall: targeting of the endothelium by pathogenic bacteria. Nat Rev Microbiol (2009) 1.16
Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes. J Biol Chem (2005) 1.14
The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond. Curr Opin Microbiol (2013) 1.08